Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

ReShape Lifesciences Will Be Issued US Patent Number 12,329,972 Tomorrow Titled "HIGH-FREQUENCY LOW DUTY CYCLE PATTERNS FOR NERUAL REGULATION (FOR TREATMENT OF GI CONDITIONS INCLUDING OBESITY & OTHER EATING DISORDERS, IBD, PANCREATITIS, DIABETES, AND HYPERTENSION)"

Author: Benzinga Newsdesk | June 16, 2025 08:08pm
Image
Image
Image

Posted In: RSLS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist